High blood pressure, or hypertension, often goes unnoticed but can lead to severe health issues like heart attack and stroke.

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.

In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

Fewer than 10 percent of people with hypertension had their blood sugar under control & fewer than 66 percent of diabetics ...

There’s mixed evidence that garlic may help lower blood pressure. However, it may not be an effective treatment option for ...

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as ...

Delayed diagnosis of hypertension after initial elevated BP measurement was tied to lower rates of antihypertensive drug ...

Researchers found a 30% increased risk of cardiovascular events in patients whose diagnosis was delayed by more than a year ...

Positive high-level results in trials of its baxdrostat drug to treat hypertension provided AstaZeneca shares with a ...

The readout is particularly welcome for AZ as baxdrostat (formerly CIN-107) showed mixed results in earlier hypertension ...

NIE reveals that Indians consume excessive salt, increasing the risk of hypertension and related diseases. To combat this, ...

AstraZeneca’s $1.3 billion bet on CinCor Pharma and its mid-phase hypertension drug baxdrostat seems to have paid off based ...